Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines.
PLoS One
; 14(10): e0223302, 2019.
Article
in En
| MEDLINE
| ID: mdl-31577826
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bilirubin
/
Insulin Resistance
/
Cytokines
/
Inflammation Mediators
/
Obesity, Abdominal
Type of study:
Prognostic_studies
Limits:
Aged
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2019
Document type:
Article
Affiliation country: